两家保险公司和一家生物科技公司股价上涨逾15%,而三家中概股IPO均下跌逾15%。
4家公司和3家SPAC(SPAC(Special Purpose Acquisition Company 即特殊目的收购公司)SPAC上市融资方式集中了直接上...查看全文
牛唐2019-10-25 08:07
$Phathom(PHAT)$
公司有四个适应症是在日本获批了的,今年四季度会在美国启动两个三期实验,结果预计2021年才会公布。公司药物几乎都是和 $武田制药(TAK)$ 、大冢制药合作的,武田也是公司的股东之一,这次IPO会认购部分股份。从业务和股东上来看,公司赢得资本市场的认可难度比较大,不建议...查看全文
$Phathom(PHAT)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-24-056888 Act: 34 Size: 7 MB 网页链接
$Phathom(PHAT)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-24-134793 Act: 34 Size: 226 KB 网页链接
$Phathom(PHAT)$ ARS Annual Report to Security Holders Accession Number: 0000950170-24-044013 Act: 34 Size: 13 MB 网页链接
$Phathom(PHAT)$ DEF 14A Other definitive proxy statements Accession Number: 0000950170-24-044015 Act: 34 Size: 3 MB 网页链接
$Phathom(PHAT)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0000950170-24-044018 Act: 34 Size: 1 MB 网页链接
$Phathom(PHAT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-043385 Size: 5 KB 网页链接
$Phathom(PHAT)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001395064-24-000025 Act: 34 Size: 49 KB 网页链接
$Phathom(PHAT)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001395064-24-000023 Act: 34 Size: 54 KB 网页链接
$Phathom制药(PHAT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-036398 Size: 5 KB 网页链接
$Phathom制药(PHAT)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-027910 Act: 34 Size: 19 MB 网页链接